Fernando Perez-Ruiz

Summary

Country: Spain

Publications

  1. pmc A review of uric acid, crystal deposition disease, and gout
    Fernando Perez-Ruiz
    Servicio de Reumatologia, Hospital Universitario Cruces, and BioCruces Health Research Institute, 48903, Baracaldo, Vizcaya, Spain
    Adv Ther 32:31-41. 2015
  2. doi request reprint Clinical manifestations and diagnosis of gout
    Fernando Perez-Ruiz
    Division of Rheumatology, BioCruces Health Institute, Hospital Universitario Cruces, Pza Cruces sn, Baracaldo 48903, Spain Electronic address
    Rheum Dis Clin North Am 40:193-206. 2014
  3. pmc Imaging of gout: findings and utility
    Fernando Perez-Ruiz
    Rheumatology Division, Hospital de Cruces, Baracaldo, Vizcaya, Spain
    Arthritis Res Ther 11:232. 2009
  4. doi request reprint Treating to target: a strategy to cure gout
    Fernando Perez-Ruiz
    Rheumatology Division, Hospital de Cruces, 48600 Baracaldo, Vizcaya, Spain
    Rheumatology (Oxford) 48:ii9-ii14. 2009
  5. doi request reprint Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with gout
    Fernando Perez-Ruiz
    Hospital de Cruces, Vizcaya, Spain
    Arthritis Care Res (Hoboken) 62:1299-305. 2010
  6. doi request reprint A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis
    Fernando Perez-Ruiz
    Servicio de Reumatologia, Hospital Universitario Cruces, Baracaldo, Vizcaya, Spain
    Arthritis Rheum 63:4002-6. 2011
  7. doi request reprint An audit of the variability of diagnosis and management of gout in the rheumatology setting: the gout evaluation and management study
    Fernando Perez-Ruiz
    Rheumatology Department, Hospital de Cruces, Baracaldo, Spain
    J Clin Rheumatol 17:349-55. 2011
  8. doi request reprint Management of gout
    F Perez-Ruiz
    Division of Rheumatology, Hospital de Cruces, Pais Vasco, Baracaldo, Spain
    Scand J Rheumatol 37:81-9. 2008
  9. doi request reprint Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout
    Fernando Perez-Ruiz
    Rheumatology Division, Hospital Universitario Cruces, Baracaldo, Vizcaya, Spain
    Ann Rheum Dis 73:177-82. 2014
  10. ncbi request reprint Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout
    Fernando Perez-Ruiz
    Hospital de Cruces, Pais Vasco, Spain
    Arthritis Rheum 47:356-60. 2002

Detail Information

Publications24

  1. pmc A review of uric acid, crystal deposition disease, and gout
    Fernando Perez-Ruiz
    Servicio de Reumatologia, Hospital Universitario Cruces, and BioCruces Health Research Institute, 48903, Baracaldo, Vizcaya, Spain
    Adv Ther 32:31-41. 2015
    ....
  2. doi request reprint Clinical manifestations and diagnosis of gout
    Fernando Perez-Ruiz
    Division of Rheumatology, BioCruces Health Institute, Hospital Universitario Cruces, Pza Cruces sn, Baracaldo 48903, Spain Electronic address
    Rheum Dis Clin North Am 40:193-206. 2014
    ..In this article, an innovative, practical, and rational approach to the clinical manifestations and diagnosis of gout is presented, which may be supportive for clinicians involved in everyday care and management of patients with gout. ..
  3. pmc Imaging of gout: findings and utility
    Fernando Perez-Ruiz
    Rheumatology Division, Hospital de Cruces, Baracaldo, Vizcaya, Spain
    Arthritis Res Ther 11:232. 2009
    ....
  4. doi request reprint Treating to target: a strategy to cure gout
    Fernando Perez-Ruiz
    Rheumatology Division, Hospital de Cruces, 48600 Baracaldo, Vizcaya, Spain
    Rheumatology (Oxford) 48:ii9-ii14. 2009
    ..In the long term, reduction in the sUA below the target level will result in gout being effectively cured...
  5. doi request reprint Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with gout
    Fernando Perez-Ruiz
    Hospital de Cruces, Vizcaya, Spain
    Arthritis Care Res (Hoboken) 62:1299-305. 2010
    ..To find factors associated with the development of renal colic during uricosuric therapy...
  6. doi request reprint A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis
    Fernando Perez-Ruiz
    Servicio de Reumatologia, Hospital Universitario Cruces, Baracaldo, Vizcaya, Spain
    Arthritis Rheum 63:4002-6. 2011
    ..This study was undertaken to reevaluate whether this stringent therapeutic target to dissolve crystals must be maintained lifelong to prevent new crystal formation...
  7. doi request reprint An audit of the variability of diagnosis and management of gout in the rheumatology setting: the gout evaluation and management study
    Fernando Perez-Ruiz
    Rheumatology Department, Hospital de Cruces, Baracaldo, Spain
    J Clin Rheumatol 17:349-55. 2011
    ....
  8. doi request reprint Management of gout
    F Perez-Ruiz
    Division of Rheumatology, Hospital de Cruces, Pais Vasco, Baracaldo, Spain
    Scand J Rheumatol 37:81-9. 2008
  9. doi request reprint Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout
    Fernando Perez-Ruiz
    Rheumatology Division, Hospital Universitario Cruces, Baracaldo, Vizcaya, Spain
    Ann Rheum Dis 73:177-82. 2014
    ....
  10. ncbi request reprint Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout
    Fernando Perez-Ruiz
    Hospital de Cruces, Pais Vasco, Spain
    Arthritis Rheum 47:356-60. 2002
    ..This observational, prospective study evaluates the relationship between serum urate levels during therapy and the velocity of reduction of tophi in patients with chronic tophaceous gout...
  11. doi request reprint Evaluation and treatment of gout as a chronic disease
    Fernando Perez-Ruiz
    Rheumatology Division, Hospital Universitario Cruces, Pza Cruces, Baracaldo, Vizcaya, Spain
    Adv Ther 29:935-46. 2012
    ..This review intends to increase the awareness of gout as a chronic deposition disease, and show that efforts should be made to properly control serum urate levels in order to achieve complete disappearance of urate crystal deposition...
  12. ncbi request reprint Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study
    Fernando Perez-Ruiz
    Seccion de Reumatologia, Hospital de Cruces, Pais Vasco, Spain
    Arthritis Rheum 55:786-90. 2006
    ..Our objective was to ascertain the outcome of ULT withdrawal after long-term, documented control of serum urate levels...
  13. ncbi request reprint Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels: another insight to allopurinol-related toxicity
    Fernando Perez-Ruiz
    Rheumatology Section, Hospital de Cruces, Vizcaya, Spain
    J Clin Rheumatol 11:129-33. 2005
    ..Dosing of allopurinol should be corrected depending on renal function, but corrections based on either plasma creatinine (Pcr) or creatinine clearance (CrCl) have been suggested to be minimal standards of care...
  14. ncbi request reprint Long-term efficacy of hyperuricaemia treatment in renal transplant patients
    Fernando Perez-Ruiz
    Hospital de Cruces, Rheumatology Section and Nephrology Division, Baracaldo, Pais Vasco, Spain
    Nephrol Dial Transplant 18:603-6. 2003
    ..We therefore examine the effects of allopurinol and benziodarone therapy in a cohort of renal transplant patients...
  15. doi request reprint Increase in thyroid stimulating hormone levels in patients with gout treated with inhibitors of xanthine oxidoreductase
    Fernando Perez-Ruiz
    Rheumatology Division, Hospital Universitario Cruces and Biocruces Health Research Institute, Pza Cruces sn, 48903, Baracaldo, Spain
    Rheumatol Int 35:1857-61. 2015
    ..Febuxostat, but also allopurinol, increased TSH levels in a dose-dependent way, thus suggesting rather a class effect than a drug effect, but with no apparent impact on either clinical or fT4 levels...
  16. ncbi request reprint Ultrasonographic measurement of tophi as an outcome measure for chronic gout
    Fernando Perez-Ruiz
    Seccion de Reumatologia and Servicio de Radiologia, Hospital de Cruces, Baracaldo, Spain
    J Rheumatol 34:1888-93. 2007
    ..To validate the usefulness of measuring tophi with ultrasonography (US) as an outcome measure for chronic tophaceous gout...
  17. doi request reprint Canakinumab for gout: a specific, patient-profiled indication
    Fernando Perez-Ruiz
    Rheumatology Division, Hospital Universitario Cruces, Vizcaya, Spain
    Expert Rev Clin Immunol 10:339-47. 2014
    ..Notwithstanding, the use of IL-1 blockade to prevent EAIs in gout looks promising, but no drug has yet obtained approval for such an indication...
  18. ncbi request reprint Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout?
    Fernando Perez-Ruiz
    Hospital de Cruces, Baracaldo, Pais Vasco, Spain
    Arthritis Rheum 57:1324-8. 2007
  19. ncbi request reprint Imaging modalities and monitoring measures of gout
    Fernando Perez-Ruiz
    Department of Rheumatology, Hospital de Cruces, Vizcaya, Spain
    Curr Opin Rheumatol 19:128-33. 2007
    ..Ultrasonography, computed tomography and magnetic resonance imaging are emerging techniques that could be used for diagnosis, evaluation, and monitoring acute and chronic gout...
  20. doi request reprint Renal clearance of uric acid is linked to insulin resistance and lower excretion of sodium in gout patients
    Fernando Perez-Ruiz
    Rheumatology Division, Hospital Universitario Cruces and Biocruces Health Research Institute, Pza Cruces sn, 48903, Baracaldo, Spain
    Rheumatol Int 35:1519-24. 2015
    ..The impact of insulin resistance and renal handling of sodium on renal clearance of uric acid may help to explain why hyperuricemia is more commonly associated with diabetes and hypertension. ..
  21. doi request reprint Epidemiology and health-related services
    Fernando Perez-Ruiz
    aRheumatology Division, Biocruces Health Research Institute bRheumatology Division, Hospital Universitario Cruces, OSI EE Cruces, Baracaldo cInstituto de Salud Musculoesquelética, Madrid, Spain
    Curr Opin Rheumatol 28:104-9. 2016
    ..This article presents recent epidemiologic contributions focusing on gout-related conditions, especially if controversial, to find plausible, despite hypothetical, mechanistic explanations from the clinician perspective...
  22. pmc EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
    W Zhang
    Academic Rheumatology, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK
    Ann Rheum Dis 65:1312-24. 2006
    ..To develop evidence based recommendations for the management of gout...
  23. pmc EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
    W Zhang
    Academic Rheumatology, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK
    Ann Rheum Dis 65:1301-11. 2006
    ..To develop evidence based recommendations for the diagnosis of gout...
  24. ncbi request reprint Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output
    F Perez-Ruiz
    Hospital de Cruces, Baracaldo, Vizcaya, Spain
    Arthritis Rheum 47:610-3. 2002
    ..To compare renal handling of uric acid in patients with primary gout with that of a control group...